1 terminated, 1 unknown. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Cyclophosphamide, fludarabine: new trials by email Literature Review of Cyclophosphamide, fludarabine trials Research Report on Cyclophosphamide, fludarabine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies CT125A cells, Cyclophosphamide, fludarabine - CD5+ Relapsed/Refractory Hematopoietic Malignancies, Chronic Lymphocytic Leukemia (CLL) | Early Phase 1 | Unknown | Huazhong University of Science and Technology | 18 | 2021-03-01 | 2021-02-23 |
| Stem Cell Transplantation for Fanconi Anemia Hematopoietic Stem Cell Transplant, Thymic Shielding During Radiation, Total Body Irradiation - Fanconi Anemia | Phase 1 / Phase 2 | Terminated | Masonic Cancer Center, University of Minnesota | 16 | 2004-03-01 | 2019-08-26 |
Fanconi Anemia (1) · Hematologic Neoplasms (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, T-Cell, Peripheral (1)
Huazhong University of Science and Technology (1) · Masonic Cancer Center, University of Minnesota (1)
United States (1)
Jianfeng Zhou, PhD, MD (1) · Margaret MacMillan, MD (1)